Concepedia

Adegoke O. Adeniji

AO

Statistics

Publications

8

Citations

429

H-Index

8

Active since

2011

Affiliations

University of Pennsylvania(Current)

Translational Therapeutics (United States)

Vanderbilt University

University of Ljubljana

Adegoke O. Adeniji is an author at University of Pennsylvania specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

2011–2019

8

Publications

8

Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on<i>N</i>-Phenyl-Aminobenzoates and Their Structure–Activity Relationships

Adegoke O. Adeniji, Barry M. Twenter, Michael C. Byrns et al. · Journal of Medicinal Chemistry · 2012 · 106 citations · Full text

, , +16

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

Andy J. Liedtke, Adegoke O. Adeniji, Mo Chen et al. · Journal of Medicinal Chemistry · 2013 · 99 citations · Full text

, , +16

Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer

Mo Chen, Adegoke O. Adeniji, Barry M. Twenter et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 66 citations · Full text

, , +11

Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

Adegoke O. Adeniji, Barry M. Twenter, Michael C. Byrns et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 48 citations · Full text

, , +12

Discovery of (<i>R</i>)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor

Adegoke O. Adeniji, Md. Jashim Uddin, Tianzhu Zang et al. · Journal of Medicinal Chemistry · 2016 · 41 citations · Full text

, , +14

1–5 of 8